The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis - He, S; Blombäck, M; Bark, N; Johnsson, H; Wallén, N H (Thromb Haemost, 2010)